Total Funding
72
59
Total FundingGrant raised
Growth Score
-8 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
30067
Monod Bio is a life sciences company developing biosensors for protein and other analyte detection.
- Daniel Silva Manzano: Co-Founder and CEOPast Role: Neoleukin Therapeutics, VP Head Of Research and Co-founder
David Shoultz: Co-Founder & COOPast Role: Bill & Melinda Gates Foundation, Director of Grantee and Partner Engagement
About the Company
Monod Bio is a life sciences company developing biosensors for protein and other analyte detection. Its biosensor platform combines binding, transduction, and amplification to detect a range of target molecules. It utilizes recent advances in computational protein engineering to create highly modular bio-sensing nano switches that stimulate rapid,
sensitive, and inexpensive analytical assays.
Monod Bio was founded in 2021 and is headquartered in Seattle, Washington.
